Global Bipolar Disorders and Treatment Market Growth 2018-2023
Published On: October 2018
 
Report ID:351881
 
 
Pages: 137




Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks.

Over the next five years, LPI(LP Information) projects that Bipolar Disorders and Treatment will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Bipolar Disorders and Treatment market for 2018-2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Bipolar Disorders and Treatment market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

Mood stabilizer

Anticonvulsant

Antipsychotic

Antidepressant

Antianxiety

Segmentation by application:

Hospital

Pharmacy

Other

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

GlaxoSmithKline

Pfizer

Janssen Pharmaceuticals

Eli Lilly

Allergan

Novartis

​​AbbVie

Otsuka Holdings

AstraZeneca

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Bipolar Disorders and Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

To understand the structure of Bipolar Disorders and Treatment market by identifying its various subsegments.

Focuses on the key global Bipolar Disorders and Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Bipolar Disorders and Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Bipolar Disorders and Treatment submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2018-2023 Global Bipolar Disorders and Treatment Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Bipolar Disorders and Treatment Consumption 2013-2023

2.1.2 Bipolar Disorders and Treatment Consumption CAGR by Region

2.2 Bipolar Disorders and Treatment Segment by Type

2.2.1 Mood stabilizer

2.2.2 Anticonvulsant

2.2.3 Antipsychotic

2.2.4 Antidepressant

2.2.5 Antianxiety

2.3 Bipolar Disorders and Treatment Consumption by Type

2.3.1 Global Bipolar Disorders and Treatment Consumption Market Share by Type (2013-2018)

2.3.2 Global Bipolar Disorders and Treatment Revenue and Market Share by Type (2013-2018)

2.3.3 Global Bipolar Disorders and Treatment Sale Price by Type (2013-2018)

2.4 Bipolar Disorders and Treatment Segment by Application

2.4.1 Hospital

2.4.2 Pharmacy

2.4.3 Other

2.5 Bipolar Disorders and Treatment Consumption by Application

2.5.1 Global Bipolar Disorders and Treatment Consumption Market Share by Application (2013-2018)

2.5.2 Global Bipolar Disorders and Treatment Value and Market Share by Application (2013-2018)

2.5.3 Global Bipolar Disorders and Treatment Sale Price by Application (2013-2018)

3 Global Bipolar Disorders and Treatment by Players

3.1 Global Bipolar Disorders and Treatment Sales Market Share by Players

3.1.1 Global Bipolar Disorders and Treatment Sales by Players (2016-2018)

3.1.2 Global Bipolar Disorders and Treatment Sales Market Share by Players (2016-2018)

3.2 Global Bipolar Disorders and Treatment Revenue Market Share by Players

3.2.1 Global Bipolar Disorders and Treatment Revenue by Players (2016-2018)

3.2.2 Global Bipolar Disorders and Treatment Revenue Market Share by Players (2016-2018)

3.3 Global Bipolar Disorders and Treatment Sale Price by Players

3.4 Global Bipolar Disorders and Treatment Manufacturing Base Distribution, Sales Area, Product Types by Players

3.4.1 Global Bipolar Disorders and Treatment Manufacturing Base Distribution and Sales Area by Players

3.4.2 Players Bipolar Disorders and Treatment Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Bipolar Disorders and Treatment by Regions

4.1 Bipolar Disorders and Treatment by Regions

4.1.1 Global Bipolar Disorders and Treatment Consumption by Regions

4.1.2 Global Bipolar Disorders and Treatment Value by Regions

4.2 Americas Bipolar Disorders and Treatment Consumption Growth

4.3 APAC Bipolar Disorders and Treatment Consumption Growth

4.4 Europe Bipolar Disorders and Treatment Consumption Growth

4.5 Middle East & Africa Bipolar Disorders and Treatment Consumption Growth

5 Americas

5.1 Americas Bipolar Disorders and Treatment Consumption by Countries

5.1.1 Americas Bipolar Disorders and Treatment Consumption by Countries (2013-2018)

5.1.2 Americas Bipolar Disorders and Treatment Value by Countries (2013-2018)

5.2 Americas Bipolar Disorders and Treatment Consumption by Type

5.3 Americas Bipolar Disorders and Treatment Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Bipolar Disorders and Treatment Consumption by Countries

6.1.1 APAC Bipolar Disorders and Treatment Consumption by Countries (2013-2018)

6.1.2 APAC Bipolar Disorders and Treatment Value by Countries (2013-2018)

6.2 APAC Bipolar Disorders and Treatment Consumption by Type

6.3 APAC Bipolar Disorders and Treatment Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Bipolar Disorders and Treatment by Countries

7.1.1 Europe Bipolar Disorders and Treatment Consumption by Countries (2013-2018)

7.1.2 Europe Bipolar Disorders and Treatment Value by Countries (2013-2018)

7.2 Europe Bipolar Disorders and Treatment Consumption by Type

7.3 Europe Bipolar Disorders and Treatment Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Bipolar Disorders and Treatment by Countries

8.1.1 Middle East & Africa Bipolar Disorders and Treatment Consumption by Countries (2013-2018)

8.1.2 Middle East & Africa Bipolar Disorders and Treatment Value by Countries (2013-2018)

8.2 Middle East & Africa Bipolar Disorders and Treatment Consumption by Type

8.3 Middle East & Africa Bipolar Disorders and Treatment Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.2 Bipolar Disorders and Treatment Distributors

10.3 Bipolar Disorders and Treatment Customer

11 Global Bipolar Disorders and Treatment Market Forecast

11.1 Global Bipolar Disorders and Treatment Consumption Forecast (2018-2023)

11.2 Global Bipolar Disorders and Treatment Forecast by Regions

11.2.1 Global Bipolar Disorders and Treatment Forecast by Regions (2018-2023)

11.2.2 Global Bipolar Disorders and Treatment Value Forecast by Regions (2018-2023)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Bipolar Disorders and Treatment Forecast by Type

11.8 Global Bipolar Disorders and Treatment Forecast by Application

12 Key Players Analysis

12.1 GlaxoSmithKline

12.1.1 Company Details

12.1.2 Bipolar Disorders and Treatment Product Offered

12.1.3 GlaxoSmithKline Bipolar Disorders and Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.1.4 Main Business Overview

12.1.5 GlaxoSmithKline News

12.2 Pfizer

12.2.1 Company Details

12.2.2 Bipolar Disorders and Treatment Product Offered

12.2.3 Pfizer Bipolar Disorders and Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.2.4 Main Business Overview

12.2.5 Pfizer News

12.3 Janssen Pharmaceuticals

12.3.1 Company Details

12.3.2 Bipolar Disorders and Treatment Product Offered

12.3.3 Janssen Pharmaceuticals Bipolar Disorders and Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.3.4 Main Business Overview

12.3.5 Janssen Pharmaceuticals News

12.4 Eli Lilly

12.4.1 Company Details

12.4.2 Bipolar Disorders and Treatment Product Offered

12.4.3 Eli Lilly Bipolar Disorders and Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.4.4 Main Business Overview

12.4.5 Eli Lilly News

12.5 Allergan

12.5.1 Company Details

12.5.2 Bipolar Disorders and Treatment Product Offered

12.5.3 Allergan Bipolar Disorders and Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.5.4 Main Business Overview

12.5.5 Allergan News

12.6 Novartis

12.6.1 Company Details

12.6.2 Bipolar Disorders and Treatment Product Offered

12.6.3 Novartis Bipolar Disorders and Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.6.4 Main Business Overview

12.6.5 Novartis News

12.7 ​​AbbVie

12.7.1 Company Details

12.7.2 Bipolar Disorders and Treatment Product Offered

12.7.3 ​​AbbVie Bipolar Disorders and Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.7.4 Main Business Overview

12.7.5 ​​AbbVie News

12.8 Otsuka Holdings

12.8.1 Company Details

12.8.2 Bipolar Disorders and Treatment Product Offered

12.8.3 Otsuka Holdings Bipolar Disorders and Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.8.4 Main Business Overview

12.8.5 Otsuka Holdings News

12.9 AstraZeneca

12.9.1 Company Details

12.9.2 Bipolar Disorders and Treatment Product Offered

12.9.3 AstraZeneca Bipolar Disorders and Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.9.4 Main Business Overview

12.9.5 AstraZeneca News

13 Research Findings and Conclusion




Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \
   Payment Mode



For More Information

   For More Information

If you have any query? Please contact us

sales@fiormarkets.com
+1-201-465-4211


Copyright © 2019 Fior Market Research LLP, All Rights Reserved.